OraPharma Revenue and Competitors

OraPharma, Inc. is a specialty pharmaceutical company that is engaged in discovering, developing and commercializing pharmaceutical products for oral healthcare. In February 2001, the Company received approval from the United States Food and Drug Administration to market the Company's first product, Arestin. The Company's other product candidates, which are in earlier stages of development, include a compound for the treatment of oral mucositis, an agent for bone and tissue regeneration, a second treatment approach for periodontitis as a follow-on to Arestin and a dental trauma treatment using Arestin. OraPharma is directing its research and development programs at further establishing a presence in oral health care pharmaceuticals and expanding the use of its core technology.